Luminist Labs YC Demo Day (W16) - Diagnostic platform for early detection of liver disease
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
![[500 STARTUPS DEMO DAY 2015] BATCH 14, Baker](https://img.youtube.com/vi/4PIaBOf5F2E/0.jpg)
![[500 STARTUPS KOBE DEMO DAY 2016] Pre-Accelerator, Analytica](https://img.youtube.com/vi/i44KvdDhASg/0.jpg)
